Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thermo Biopolymer (also known as Thermo Biopolymers) is a specialized business unit of Thermo Fisher Scientific based in Ulm, Germany. Originally founded as Interactiva Biotechnologie GmbH in 1996, the company was acquired by Thermo BioAnalysis (a spin-out of Thermo Electron) in 1999 and subsequently integrated into the Thermo Fisher Scientific portfolio. The company is a leading provider of custom biopolymer synthesis services, specializing in synthetic peptides, oligonucleotides, and stable isotope-labeled (SIL) proteotypic peptides. Its products are essential tools for quantitative proteomics, biomarker discovery, and metabolic research, serving major pharmaceutical companies and academic institutions worldwide. The Ulm facility serves as a center of excellence for peptide chemistry and custom biopolymer production within Thermo Fisher Scientific's Biosciences division. The company's expertise in stable isotope labeling has made it a preferred partner for researchers developing mass spectrometry-based assays for protein quantification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thermo Biopolymer.